CareDx (CDNA) Tops Q1 EPS by 28c ; Offers Guidance
CareDx (NASDAQ: CDNA) reported Q1 EPS of $0.09, $0.28 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $84.7 million versus the consensus estimate of $84.37 million.
GUIDANCE:
CareDx sees FY2025 revenue of $365-375 million, versus the consensus of $370.9 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.
